Influence of Oral Vitamin C Supplement on the Inflammation Status in Dialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
UremiaInflammation
Interventions
DRUG

oral vitamin C

"cross-over study,2 arms Arm 1(50cases): is given oral vitamin C 200mg per day in the first 3 months, then stop oral VitC for the next 3 months.~Arm 2(50cases): is not given vitamin C in the first 3 months, then switch to receive oral VitC 200mg per day in the next 3 months."

DRUG

oral vitamin C

Arm 2(50cases): is not given vitamin C in the first 3 months, then switch to receive oral VitC 200mg per day in the next 3 months.

Trial Locations (1)

100034

hemodialysis center of Renal Division, Department of Medicine, Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT01356433 - Influence of Oral Vitamin C Supplement on the Inflammation Status in Dialysis Patients | Biotech Hunter | Biotech Hunter